hrefna ,
@hrefna@hachyderm.io avatar

bangs head into table repeatedly

From "Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population (Aranda et al, 2021)

Finasteride therapy (5α-reductase inhibitor) has effectively improved hair loss in transgender women with androgenic alopecia without significant side effects. Nevertheless, the routine use of 5α-reductase inhibitors has been limited over previous concerns of long-term sexual dysfunction and depression reported in cisgender men (23, 24).
ALT
  • Reply
    • wikicliff ,
    @wikicliff@fosstodon.org avatar

    @hrefna
    <notices headbanging>:
    "Concussion Risk Associated With Study Analysis in Transgender Population" 😜

    hrefna OP ,
    @hrefna@hachyderm.io avatar

    Article: <discusses concerns with progesterone>
    Article: <uses as an example a version that is not used for this purpose any longer>
    Article: <proceeds to cite two papers based on progestins at least one of which was focused on postmenopausal cis women>

    Progesterone therapies such as medroxyprogesterone have been used to reduce testosterone concentrations in transgender women (19). Some may ask for progesterone to enhance breast development; however, clinical evidence does not support this effect (20). Furthermore, there are concerns regarding the potential increased risk of thromboembolism and stroke found in cisgender women taking progesterone (21, 22).
    ALT
  • Reply
    • SoniEx2 ,
    @SoniEx2@chaos.social avatar

    @hrefna smh

  • All
  • Subscribed
  • Moderated
  • Favorites
  • •
  • random
  • test
  • worldmews
  • mews
  • All magazines
    •